Van Eck Associates Corp Moderna, Inc. Transaction History

Van Eck Associates Corp

$80.1 Billion
Q3 2024

A detailed history of Van Eck Associates Corp transactions in Moderna, Inc. stock. As of the latest transaction made, Van Eck Associates Corp holds 266,929 shares of MRNA stock, worth $10.9 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

266,929

Previous 152,160 75.43%

Holding current value

$10.9 Million

Previous $18.1 Million 21.13%

% of portfolio

0.02%

Previous 0.03%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	BUY	$63.64 - $125.14 $7.3 Million - $14.4 Million	114,769 Added 75.43%	266,929 $14.3 Million
Q2 2024 Jul 31, 2024	SELL	$101.21 - $166.61 $8.21 Million - $13.5 Million	-81,086 Reduced 34.76%	152,160 $18.1 Million
Q1 2024 Apr 30, 2024	SELL	$85.37 - $115.44 $3.2 Million - $4.33 Million	-37,528 Reduced 13.86%	233,246 $24.9 Million
Q4 2023 Feb 05, 2024	BUY	$69.51 - $104.43 $3.03 Million - $4.56 Million	43,646 Added 19.22%	270,774 $26.9 Million
Q3 2023 Nov 08, 2023	BUY	$96.41 - $126.61 $2.38 Million - $3.13 Million	24,698 Added 12.2%	227,128 $23.5 Million
Q2 2023 Aug 03, 2023	BUY	$118.5 - $160.53 $1.13 Million - $1.53 Million	9,552 Added 4.95%	202,430 $24.6 Million
Q1 2023 May 03, 2023	BUY	$135.66 - $197.02 $2.07 Million - $3.01 Million	15,285 Added 8.61%	192,878 $29.6 Million
Q4 2022 Feb 08, 2023	SELL	$118.38 - $210.04 $3.77 Million - $6.7 Million	-31,887 Reduced 15.22%	177,593 $31.9 Million
Q3 2022 Oct 27, 2022	BUY	$118.07 - $194.18 $1.58 Million - $2.59 Million	13,342 Added 6.8%	209,480 $24.8 Million
Q2 2022 Aug 03, 2022	SELL	$117.13 - $176.59 $12 Million - $18.1 Million	-102,523 Reduced 34.33%	196,138 $28 Million
Q1 2022 May 10, 2022	BUY	$126.46 - $235.05 $122,033 - $226,823	965 Added 0.32%	298,661 $51.4 Million
Q4 2021 Jan 26, 2022	BUY	$225.82 - $368.51 $23.8 Million - $38.8 Million	105,382 Added 54.8%	297,696 $75.6 Million
Q3 2021 Nov 03, 2021	BUY	$221.9 - $484.47 $8.05 Million - $17.6 Million	36,282 Added 23.25%	192,314 $74 Million
Q2 2021 Aug 10, 2021	SELL	$129.91 - $234.98 $8.96 Million - $16.2 Million	-68,988 Reduced 30.66%	156,032 $36.7 Million
Q1 2021 May 13, 2021	BUY	$109.18 - $185.98 $5.94 Million - $10.1 Million	54,419 Added 31.9%	225,020 $29.5 Million
Q4 2020 Feb 09, 2021	SELL	$65.74 - $169.86 $11.9 Million - $30.8 Million	-181,467 Reduced 51.54%	170,601 $17.8 Million
Q3 2020 Nov 12, 2020	SELL	$54.34 - $94.85 $682,184 - $1.19 Million	-12,554 Reduced 3.44%	352,068 $24.9 Million
Q2 2020 Aug 10, 2020	SELL	$29.67 - $80.0 $2.54 Million - $6.84 Million	-85,492 Reduced 18.99%	364,622 $23.4 Million
Q1 2020 May 12, 2020	BUY	$17.78 - $31.58 $8 Million - $14.2 Million	450,114 New	450,114 $13.5 Million

Others Institutions Holding MRNA

# of Institutions

953

Shares Held

241M

Call Options Held

10.6M

Put Options Held

18.7M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $15.9B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Van Eck Associates Corp, based on Form 13F filings with the SEC.

News

Stay updated on Van Eck Associates Corp with notifications on news.

Account

Van Eck Associates Corp Moderna, Inc. Transaction History